Bioline Launches New SensiFAST(TM) Lyo-Ready No-ROX Mix
(Thomson Reuters ONE) -
CINCINNATI, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Bioline, The PCR Company, a
wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to
announce the worldwide release of the SensiFAST Lyo-Ready No-ROX Mix from
Bioline to add to the SensiFAST family of real-time PCR products.
Bioline has developed a ready-to-use, lyophilization-compatible qPCR mix, the
SensiFAST Lyo-Ready No-ROX Mix. The SensiFAST Lyo-Ready No-ROX Mix has exactly
the same fast, highly reproducible performance as the SensiFAST 'wet'
formulation, however the SensiFAST Lyo-Ready No-ROX Mix can be lyophilized with
customer supplied assay-specific primers and probes and stored at room
temperature, making it ideal for automated, high throughput systems.
Marco Calzavara, President of Bioline commented, "I am delighted to announce the
release of SensiFAST Lyo-Ready No-ROX Mix as a new member of our real-time PCR-
based SensiFAST family. This new mix will enable researchers to lyophilize and
store their real-time PCR assays at room temperature, reducing the risks
associated with storage and shipping requirements."
Richard L. Eberly, President, Chief Commercial Officer, stated, "We are
delighted to release the SensiFAST Lyo-Ready No-ROX Mix as it is ideal for in-
vitro diagnostic manufacturers, clinical diagnostic laboratories, Biotech and
biopharmaceutical companies, in reducing cold storage space, product and time
wastage, while maintaining the sensitivity and reproducibility expected with the
SensiFAST qPCR kits. We remain committed to bringing innovation and quality
products such as the SensiFAST Lyo-Ready No-ROX Mix to our research and
industrial customers around the world."
About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops, manufactures,
markets and distributes a broad range of innovative diagnostic test kits,
purified reagents and related products and offers biopharmaceutical enabling
technologies. Utilizing a variety of methods, these products and diagnostic
tests provide accuracy, simplicity and speed in the early diagnosis and
treatment of common medical conditions, such as gastrointestinal, viral and
respiratory infections and blood lead levels. Meridian's diagnostic products are
used outside of the human body and require little or no special equipment. The
Company's products are designed to enhance patient well-being while reducing the
total outcome costs of health care. Meridian has strong market positions in the
areas of gastrointestinal and upper respiratory infections; serology,
parasitology and fungal disease diagnosis, and blood lead level testing. In
addition, Meridian is a supplier of rare reagents, specialty biologicals and
related technologies used by biopharmaceutical companies engaged in research for
new drugs and vaccines. The Company markets its products and technologies to
hospitals, reference laboratories, research centers, diagnostics manufacturers
and biotech companies in more than 70 countries around the world. The Company's
shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian's
website address iswww.meridianbioscience.com.
For Additional information:
For more information about Bioline, please visit http://www.bioline.com.
CONTACT:
Richard L. Eberly
President, Chief Commercial Officer
Meridian Bioscience, Inc.
Phone: 513.271.3700
Rick.eberly(at)meridianbioscience.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Meridian Bioscience, Inc. via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 20.09.2016 - 20:44 Uhr
Sprache: Deutsch
News-ID 496043
Anzahl Zeichen: 4185
contact information:
Town:
Cincinnati
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 186 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Bioline Launches New SensiFAST(TM) Lyo-Ready No-ROX Mix"
steht unter der journalistisch-redaktionellen Verantwortung von
Meridian Bioscience, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
